Comunicado de prensa comercial

GEA equips new Biopharma plant in Ukraine with new separator technology for blood plasma fractionation

07 Apr 2021

GEA suministra separadores a la empresa ucraniana Biopharma. (Foto: GEA)

GEA suministra separadores a la empresa ucraniana Biopharma. (Foto: GEA)

Para el fraccionamiento del plasma sanguíneo se utilizan separadores de última generación. (Foto: GEA)

Para el fraccionamiento del plasma sanguíneo se utilizan separadores de última generación. (Foto: GEA)

With the new plant, GEA will enable its customer Biopharma not only to supply Ukraine with high-quality products, but also to take a leading position in the world ranking of high-tech plasma processors. (Photo: GEA)

With the new plant, GEA will enable its customer Biopharma not only to supply Ukraine with high-quality products, but also to take a leading position in the world ranking of high-tech plasma processors. (Photo: GEA)

Contact

Dr. Michael Golek

Media Relations

GEA Group Aktiengesellschaft

Ulmenstrasse 99


40476

Düsseldorf


Germany

+49 211 9136-0

About GEA

GEA es uno de los mayores proveedores para la industria alimentaria y para muchos otros sectores de la industria. En 2019 generó unos ingresos consolidados de 4.900 millones de euros aproximadamente.

Stay informed!

Are you a journalist? Then sign up to our press mailing list and select the topics you would like to be informed about

Media Relations

GEA Group Aktiengesellschaft
Ulmenstrasse 99
40476 Düsseldorf
Germany
pr@gea.com